Restrictions apply, including for people with government-funded insurance plans like Medicare or Medicaid, who are not eligible for the offer
Other combinations of entero-pancreatic hormones including cagrisema (GLP-1/amylin RA) and the triple agonist retatrutide (GLP-1/GIP/glucagon RA) have also progressed to phase 3 trials as obesity treatments and early data suggests that may lead to even greater WL than tirzepatide
Gastroparesis: Ozempic slows down stomach emptying, which can worsen gastroparesis, a condition characterized by delayed stomach emptying and symptoms like nausea and vomiting
While the pharmacological profile and cardiometabolic benefits of GLP-1 RAs make them a promising candidate for adjunctive use in smoking cessation, more rigorous randomized controlled trials are required to confirm efficacy, evaluate safety, and establish clinical guidelines
Jehangir to adjust your treatment recommendations based on your progress as needed